4th ECS Heart Failure Conference 2021
11th March 2021

Time PLENARY SESSION
12:00 12:30 Satellite Symposium
12:30 13:00 Networking Break
Session I: A Decisive Year in Heart Failure
13:00 13:15 How Heart Failure Became the Ultimate Intersection of Diabetes and CV Disease
13:15 13:30 Choosing the Right Patient for Percutaneous Mitral Interventions in HF
13:30 13:45 Neuromodulation in HF- Is it Promising?
13:45 14:00 What’s new and upcoming in Mechanical Circulatory Support?
14:00 14:15 Panel Discussion
Official Opening and Keynote Session
14:15 14:25 Welcome Address
14:25 14:55 Keynote Lecture: What did COVID-19 Pandemic Teach Us About HF Management?
14:55 15:10 Panel Discussion
15:10 15:30 Networking Break
Session II: Debates in Heart Failure
15:30 16:15 The Four “Pillars” of Medical Therapy in HFrEF Should be Started Together, not in Sequence!

15:30- 15:45: Proponent:
15:45- 16:00: Opponent:
16:00- 16:05: Rebuttal:
16:05- 16:10: Rebuttal:

16:15 17:00 Ablation Should be the First Line of Management for AF in HF Patients

16:15- 16:30: Proponent:
16:30- 16:45: Opponent:
16:45- 16:50: Rebuttal:
16:50- 16:55: Rebuttal:

17:00 17:45 Satellite Symposium

12th March 2021

Time PLENARY SESSION Time BREAKOUT SESSION
7:30 8:30 Check-in
Session III: HFpEF, The Great Masquerader
8:30 8:45 Diagnosis of HFpEF and Clinical Phenotypes
8:45 9:00 The Role of Imaging in Newly Diagnosed HFpEF
9:00 9:15 Challenges and Intricacies of HFpEF Therapies
9:15 9:30 Diabetic Cardiomyopathy: an Under-recognized Cause of HFpEF
9:30 9:45 Panel Discussion
Session IV: Hot Topics in Mechanical Circulatory Support Workshop I: Case Based Approach to Heart Failure Medication Management
9:45 10:00 Bridging from Temporary to Durable Devices- It is all About Timing 9:45 10:00 Patients with CKD, DM and HF:
10:00 10:15 Having a Crystal Ball for the RV 10:00 10:15 Patients with Pulmonary Hypertension
10:15 10:30 Bleeding and Thrombosis- Tips for Success 10:15 10:30 Patients with Iron Deficiency
10:30 10:45 Recovery with LVAD Therapy- When and How? 10:30 10:45 Patients with Temporary MCS (ECMO, Impella):
10:45 11:00 Panel Discussion 10:45 11:00 Panel Discussion
11:00 11:15 Networking Break 11:00 11:15 Networking Break
Keynote Session II
11:15 11:45 TV Interventions- The Right Patient, The Right Procedure
11:45 12:00 Panel Discussion
12:00 14:00 Prayer and Lunch Break
13:15 14:00 Satellite Symposium
Session V: Controversy or Commonplace? Incorporating New Agents and New Data into Advanced HFrEF Management Workshop II: Cardio-renal Metabolic Discussions in HF
SGLT2 Inhibitors: A Multisystem Impact
14:00 14:15 Cardiac Myosin Activators and Oral Guanylate Cyclase Stimulators in HFrEF 14:00 14:15 The Diabetologist Perspective
14:15 14:30 The Shock Team and Outcomes in Cardiogenic Shock 14:15 14:30 The Cardiologist Perspective
14:30 14:45 From Implantation to Destination: Optimizing Medical Therapy While on LVAD 14:30 14:45 The Nephrologist Perspective
14:45 15:00 Best Evidence in Preventing and Monitoring Rejection in Heart Transplant Recipients 14:45 15:00 Panel Discussion
15:00 15:15 Panel Discussion
15:15 15:30 Networking Break 15:15 15:30 Networking Break
Session VI: Updates on Cardiomyopathies Workshop II: Cardio-renal Metabolic Discussions in HF
GLP1 Agonists: A Multisystem Impact
15:30 15:45 Inherited Cardiomyopathies 15:30 15:45 The Diabetologist Perspective
15:45 16:00 Peripartum Cardiomyopathy 15:45 16:00 The Cardiologist Perspective
16:00 16:15 Inflammatory/ Infectious myocarditis 16:00 16:15 The Nephrologist Perspective
16:15 16:30 Stress-induced Cardiomyopathy 16:15 16:30 Panel Discussion
16:30 16:45 Panel Discussion
Keynote Session III
16:45 17:15 Hypertrophic Cardiomyopathy- Updates on Therapeutics and Risk Stratification
17:15 17:30 Panel Discussion
17:30 18:00 Satellite Symposium

13th March 2021

Time   PLENARY SESSION Time BREAKOUT SESSION  
7:30 8:30 Check-in
Session VII: Updates on Cardio-oncology
8:30 8:45 A Case from My Clinic
8:45 9:00 Imaging and Biomarkers in Cardio-oncology
9:00 9:15 Guidelines on Risk Stratification
9:15 9:30 Primary and Secondary Prevention of Chemotherapy-induced Cardiomyopathy
9:30 9:45 Panel Discussion
9:45 10:15 Satellite Symposium
Session VIII: Heart Meets Kidney- Common Challenges in Heart Failure and Renal Disease Workshop III: Read with the Experts: Case Studies in Heart Failure and Cardiomyopathies
10:15 10:30 The Challenge of Choosing Safe and Effective Medications 10:15 10:30 Patients with Newly Diagnosed LV Systolic Dysfunction
10:30 10:45 The Challenge of Hyperkalemia 10:30 10:45 Patients with HFpEF and LVH
10:45 11:00 The Challenge of Diuretic Resistance and Safe Volume Removal 10:45 11:00 Patients with Unexplained HF and Arrhythmia.
11:00 11:15 The Challenge of Iron Deficiency and Anemia 11:00 11:15 Young Patients with Acute HF Requiring MCS.
11:15 11:30 Panel Discussion 11:15 11:30 Panel Discussion
11:30 11:45 Networking Break 11:30 11:45 Networking Break
Session IX: Appropriate Use in HF Management
11:45 12:00 Using Invasive Hemodynamics in Acute Heart Failure Management
12:00 12:15 Using Viability Testing to Guide Revascularization in Ischemic Cardiomyopathy
12:15 12:30 Using TAVR for Moderate AS in HF
12:30 12:45 Using ICD Therapy with New Classes of Medications
12:45 13:00 Panel Discussion
13:00 14:00 Lunch Break
13:30 14:00 Satellite Symposium
Session X: Cases From the HF Clinic- Practical Considerations. Workshop IV: The Multidisciplinary HF Team in Action.
14:00 14:15 A Case of HF with Congenital Heart Disease. 14:00 14:15
14:15 14:30 A Case of Acute Decompensated HF 14:15 14:30
14:30 14:45 A Case of HFrEF with severe MR 14:30 14:45
14:45 15:00 A Case of HF Patient Needing Inotropes 14:45 15:00
15:00 15:15 Panel Discussion 15:00 15:15 Panel Discussion
15:15 15:25 Closing